QBE – From bad to worse and back to bad

After a dramatic fall the stock price might finally have bottomed.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's been a wild and rocky two weeks for shareholders in QBE Insurance (ASX: QBE). What began with a trading halt on 6 December was followed on 9 December by an announcement relating to its North American division's claim provisions and a subsequent writedown of goodwill. The response by investors saw the stock plunge initially around 19% to $12.50 having traded previously at $15.45.

By the end of the first week (13 December) the stock had continued to trend downwards to $10.50 – a fall of over 30% from the pre-announcement trading price.

While that was bad, things got even worse this week as QBE's share price continued to fall, reaching a low of $10.05 on 18 December. It appears that at the $10 mark the insurer finally found some support, no doubt helped by analysts at Commonwealth Bank (ASX: CBA), which came out and upgraded the stock to "overweight" from "neutral". Since Wednesday the share price has bounced back over 10% to be trading near $11.30 at midday Friday.

Shareholders will be hopeful that the worst of the selling is now finally over and that the beaten down stock price will continue to be supported. However the uncertainty surrounding the outlook for earnings as well as the insurers provisioning will likely be a cloud hanging over the firm for quite some time to come.

In significant contrast to the knocked down valuation being applied to QBE, in other insurance related news this week, the market rumour that Wesfarmers (ASX: WES) was preparing to offload its Insurance division turned out to be true with the announcement that the conglomerate had agreed to sell the business to Insurance Australia Group (ASX: IAG) for $1.845 billion.

Foolish takeaway

Insurance is both a cyclical business and also a complex business to understand. While investors such as Warren Buffett have proved that enormous wealth can be generated from owning insurers, many other successful investors have often shied away from the sector.

Motley Fool contributor Tim McArthur owns shares in QBE Insurance.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »